ArticlePloS one2022

The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study.

Amanda Leiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.